SAMDaily.us | SNOTE | 66 | Human Induced Pluripotent Stem Cell-Derived Cells

SAMDAILY.US - ISSUE OF APRIL 27, 2023 SAM #7821
SPECIAL NOTICE

66 -- Human Induced Pluripotent Stem Cell-Derived Cells

Notice Date: 4/25/2023 5:04:25 AM
Notice Type: Special Notice
NAICS: 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Contracting Office: FDA OFFICE OF ACQ GRANT SVCS Beltsville MD 20705 USA
ZIP Code: 20705
Solicitation Number: NOI_FDA-SS-117482
Response Due: 5/5/2023 5:00:00 AM
Point of Contact: Nicole Craig
E-Mail Address: nicole.craig@fda.hhs.gov
(nicole.craig@fda.hhs.gov)
Description: The purpose of this notice is to inform the public that the FDA anticipates issuing a sole source award to procure Human Induced Pluripotent Stem Cell-Derived Cells. (SEE ATTACHMENT for INFORMATION).
Web Link: SAM.gov Permalink
(https://sam.gov/opp/178d0ad4d0714dc6a390ef880eea0f87/view)
Place of Performance: Address: Silver Spring, MD 20993, USA; Zip Code: 20993; Country: USA
Record: SN06661303-F 20230427/230425230112 (samdaily.us)
Source: SAM.gov Link to This Notice
(may not be valid after Archive Date)

| FSG Index | This Issue's Index | Today's SAM Daily Index Page |